bioRxiv Science⌕ Search

Biology subjects

Lopez-Diazguerrero, N. E.

Publications and source records attributed to Lopez-Diazguerrero, N. E..

3 recordsLinked to original sources

Towards a Rosetta Stone to Decipher the Survival Networks of Senescence

Cellular senescence, an irreversible state of cell cycle arrest in response to various stressors that can damage cells, is a key player in developing and progressing multiple chronic degenerative diseases associated with aging. Over the years, these senescent cells accumulate in organs and tissues, it is thought that the accumulation of these cells results from their capacity to evade programmed cell death by developing and activating Senescent Cell Anti-apoptotic Pathways (SCAPs); however, numerous aspects of the development and activation of these SCAPs are still unknown. In this study, we analyzed the variations in the expression levels and co-expression patterns of 39 SCAPs genes across 33 tissues from young and elderly individuals. Surprisingly, we did not observe a consistent increase in SCAPs gene expression with age in any tissue. Instead, we found tissue-specific variations in gene expression levels, changes in the strength of gene coordination, and the wiring and rewiring of gene co-expression networks that depend on the tissue. Our results suggest that the development and activation of SCAPs are far more complex than previously understood; merely increasing the expression of specific survival genes would not adequately explain the anti-apoptotic capabilities of senescent cells. We suggest that the formation and triggering of SCAPs entail a complex interplay of factors, encompassing distinct alterations in expression levels alongside shifts in the intensity and configurations of gene interactions, moreover, these modifications are unique to individual tissues. Our results deepen our understanding of how senescent cells evade programmed cell death and are essential for developing targeted pharmacological therapies that can selectively and safely eliminate senescent cells more effectively.

cell biology↗

Discovery and Repurposing of Multi-Target Senolytics through Structure-Based Virtual Screening

Cellular Senescence is a state of irreversible cell cycle arrest in response to various stressors that can damage the cell. Senescent Cells (SCs) exhibit multiple alterations at the morphological and molecular levels, one of the most significant being the development and activation of Senescent Cell Anti-Apoptotic Pathways (SCAPs). Due to this characteristic, SCs accumulate in organs and tissues during aging. The accumulation of these cells has been associated with the onset and progression of various chronic degenerative diseases, and their selective elimination allows for the slowing down, halting, and reversing of many age-associated ailments. Small molecules called senolytics, which inhibit SCAPs, have been proposed to selectively eliminate SCs. Herein, we identified new senolytics through computational and rational drug design approaches. Among the identified molecules are the FDA-approved drug tolvaptan, the experimental Phase II drug sotrastaurin, and the experimental drugs cryptotanshinone and bicuculline. The effectiveness of these molecules in targeting senescent cells was confirmed through experiments using two different models of cellular senescence in human lung fibroblasts. Our results suggest that some molecules work by selectively inducing apoptosis through a multi-target mechanism, inhibiting several SCAPs, including PIK3CD, SERPINE1, EFNB1, and PDGFB. These newly identified FDA-approved and experimental drugs have the potential to be repurposed as new senolytic agents.

bioinformatics↗

Transcriptomic signatures and network-based methods uncover new Senescent Cell Anti-Apoptotic Pathways and Senolytics

Cellular senescence is an irreversible cell cycle arrest caused by various stressors that damage cells. Over time, senescent cells accumulate and contribute to the progression of multiple age-related degenerative diseases. It is believed that these cells accumulate partly due to their ability to evade programmed cell death through the development and activation of survival and anti-apoptotic resistance mechanisms; however, many aspects of how these survival mechanisms develop and activate are still unknown. By analyzing transcriptomic signature profiles generated by the LINCS L1000 project and using network-based methods, we identified various genes that could represent new senescence-related survival mechanisms. Additionally, employing the same methodology, we identified over 600 molecules with potential senolytic activity. Experimental validation of our computational findings confirmed the senolytic activity of Fluorouracil, whose activity would be mediated by a multi-target mechanism, revealing that its targets AURKA, EGFR, IRS1, SMAD4, and KRAS are new senescence-associated survival and anti-apoptotic resistance pathways. The development of these pathways could depend on the stimulus that induces cellular senescence. The SCAPs development and activation mechanisms proposed in this work offer new insights into how senescent cells survive. Identifying new anti-apoptotic resistance targets and drugs with potential senolytic activity paves the way for developing new pharmacological therapies to eliminate senescent cells selectively. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=125 SRC="FIGDIR/small/596326v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@137c0d4org.highwire.dtl.DTLVardef@154af55org.highwire.dtl.DTLVardef@c32030org.highwire.dtl.DTLVardef@765ee4_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗